Activation of PPAR by Rosiglitazone Does Not Negatively Impact Male Sex Steroid Hormones in Diabetic Rats
Figure 2
Representative photomicrographs of hematoxylin-eosin-stained sections of testis of nondiabetic Zucker lean control (Lean C, panel 1), Zucker diabetic fatty (ZDF) untreated (Diabetic U, panel 2), and ZDF rats treated with rosiglitazone (Diabetic T, panel 3). Arrows indicate germ cells strewn in the lumen of seminiferous tubules.